Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 159

    1.

    Expression profiling to predict outcome in breast cancer: the influence of sample selection.

    Gruvberger SK, Ringnér M, Edén P, Borg A, Fernö M, Peterson C, Meltzer PS.

    Breast Cancer Res. 2003;5(1):23-6. Epub 2002 Oct 11.

    PMID:
    12559041
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Expression profiling predicts outcome in breast cancer.

    van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Bernards R, Friend SH.

    Breast Cancer Res. 2003;5(1):57-8. Epub 2002 Dec 4. No abstract available.

    PMID:
    12559048
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    3.

    Expression profiling to predict postoperative prognosis for estrogen receptor-negative breast cancers by analysis of 25,344 genes on a cDNA microarray.

    Nagahata T, Onda M, Emi M, Nagai H, Tsumagari K, Fujimoto T, Hirano A, Sato T, Nishikawa K, Akiyama F, Sakamoto G, Kasumi F, Miki Y, Tanaka T, Tsunoda T.

    Cancer Sci. 2004 Mar;95(3):218-25.

    PMID:
    15016320
    [PubMed - indexed for MEDLINE]
    4.

    Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.

    Rody A, Karn T, Gätje R, Kourtis K, Minckwitz G, Loibl S, Munnes M, Ruckhäberle E, Holtrich U, Kaufmann M, Ahr A.

    Zentralbl Gynakol. 2006 Apr;128(2):76-81.

    PMID:
    16673249
    [PubMed - indexed for MEDLINE]
    5.

    Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis.

    Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, Smeds J, Nordgren H, Farmer P, Praz V, Haibe-Kains B, Desmedt C, Larsimont D, Cardoso F, Peterse H, Nuyten D, Buyse M, Van de Vijver MJ, Bergh J, Piccart M, Delorenzi M.

    J Natl Cancer Inst. 2006 Feb 15;98(4):262-72.

    PMID:
    16478745
    [PubMed - indexed for MEDLINE]
    Free Article
    6.

    Predicting continuous values of prognostic markers in breast cancer from microarray gene expression profiles.

    Gruvberger-Saal SK, Edén P, Ringnér M, Baldetorp B, Chebil G, Borg A, Fernö M, Peterson C, Meltzer PS.

    Mol Cancer Ther. 2004 Feb;3(2):161-8.

    PMID:
    14985456
    [PubMed - indexed for MEDLINE]
    Free Article
    7.

    Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.

    Esteva FJ, Sahin AA, Cristofanilli M, Coombes K, Lee SJ, Baker J, Cronin M, Walker M, Watson D, Shak S, Hortobagyi GN.

    Clin Cancer Res. 2005 May 1;11(9):3315-9.

    PMID:
    15867229
    [PubMed - indexed for MEDLINE]
    Free Article
    8.

    Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors.

    Pusztai L, Ayers M, Stec J, Clark E, Hess K, Stivers D, Damokosh A, Sneige N, Buchholz TA, Esteva FJ, Arun B, Cristofanilli M, Booser D, Rosales M, Valero V, Adams C, Hortobagyi GN, Symmans WF.

    Clin Cancer Res. 2003 Jul;9(7):2406-15.

    PMID:
    12855612
    [PubMed - indexed for MEDLINE]
    Free Article
    9.

    Meta-analysis and gene set enrichment relative to er status reveal elevated activity of MYC and E2F in the "basal" breast cancer subgroup.

    Alles MC, Gardiner-Garden M, Nott DJ, Wang Y, Foekens JA, Sutherland RL, Musgrove EA, Ormandy CJ.

    PLoS One. 2009;4(3):e4710. Epub 2009 Mar 9.

    PMID:
    19270750
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    10.

    Genes that co-cluster with estrogen receptor alpha in microarray analysis of breast biopsies.

    Dressman MA, Walz TM, Lavedan C, Barnes L, Buchholtz S, Kwon I, Ellis MJ, Polymeropoulos MH.

    Pharmacogenomics J. 2001;1(2):135-41.

    PMID:
    11911440
    [PubMed - indexed for MEDLINE]
    11.

    Laser microdissection and microarray analysis of breast tumors reveal ER-alpha related genes and pathways.

    Yang F, Foekens JA, Yu J, Sieuwerts AM, Timmermans M, Klijn JG, Atkins D, Wang Y, Jiang Y.

    Oncogene. 2006 Mar 2;25(9):1413-9.

    PMID:
    16261164
    [PubMed - indexed for MEDLINE]
    12.

    Identification of a robust gene signature that predicts breast cancer outcome in independent data sets.

    Korkola JE, Blaveri E, DeVries S, Moore DH 2nd, Hwang ES, Chen YY, Estep AL, Chew KL, Jensen RH, Waldman FM.

    BMC Cancer. 2007 Apr 11;7:61.

    PMID:
    17428335
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    13.

    Low expression of a few genes indicates good prognosis in estrogen receptor positive breast cancer.

    Buechler S.

    BMC Cancer. 2009 Jul 20;9:243.

    PMID:
    19619298
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    Challenges in projecting clustering results across gene expression-profiling datasets.

    Lusa L, McShane LM, Reid JF, De Cecco L, Ambrogi F, Biganzoli E, Gariboldi M, Pierotti MA.

    J Natl Cancer Inst. 2007 Nov 21;99(22):1715-23. Epub 2007 Nov 13.

    PMID:
    18000217
    [PubMed - indexed for MEDLINE]
    Free Article
    15.

    High expression of two genes selected by iAFLP: a new prognostic factor of estrogen receptor-positive breast cancer.

    Aritake N, Tamaki Y, Masuda N, Nakano Y, Monden T, Noguchi S, Monden M.

    Oncol Rep. 2004 Aug;12(2):381-7.

    PMID:
    15254706
    [PubMed - indexed for MEDLINE]
    16.

    Current status of prognostic profiling in breast cancer.

    Pusztai L.

    Oncologist. 2008 Apr;13(4):350-60. Review.

    PMID:
    18448548
    [PubMed - indexed for MEDLINE]
    Free Article
    17.

    Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers.

    Oh DS, Troester MA, Usary J, Hu Z, He X, Fan C, Wu J, Carey LA, Perou CM.

    J Clin Oncol. 2006 Apr 10;24(11):1656-64. Epub 2006 Feb 27.

    PMID:
    16505416
    [PubMed - indexed for MEDLINE]
    18.

    Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns.

    Gruvberger S, Ringnér M, Chen Y, Panavally S, Saal LH, Borg A, Fernö M, Peterson C, Meltzer PS.

    Cancer Res. 2001 Aug 15;61(16):5979-84.

    PMID:
    11507038
    [PubMed - indexed for MEDLINE]
    Free Article
    19.

    Molecular identification of ERalpha-positive breast cancer cells by the expression profile of an intrinsic set of estrogen regulated genes.

    Weisz A, Basile W, Scafoglio C, Altucci L, Bresciani F, Facchiano A, Sismondi P, Cicatiello L, De Bortoli M.

    J Cell Physiol. 2004 Sep;200(3):440-50.

    PMID:
    15254972
    [PubMed - indexed for MEDLINE]
    20.

    T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers.

    Rody A, Holtrich U, Pusztai L, Liedtke C, Gaetje R, Ruckhaeberle E, Solbach C, Hanker L, Ahr A, Metzler D, Engels K, Karn T, Kaufmann M.

    Breast Cancer Res. 2009;11(2):R15. Epub 2009 Mar 9.

    PMID:
    19272155
    [PubMed - indexed for MEDLINE]
    Free PMC Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk